Seattle Genetics Reports Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Former emir of Qatar, Sheikh Hamad bin Khalifa Al Thani, dies at 74
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Apple sues OpenAI, two former employees for trade secrets theft
Seattle Genetics (SGEN) Misses Q2 EPS by 11c, Revenues Beat; Offers FY19 Revenue Guidance
July 16, 2019 4:05 PM EDTSeattle Genetics (NASDAQ: SGEN) reported Q2 EPS of ($0.49), $0.11 worse than the analyst estimate of ($0.38). Revenue for the quarter came in at $28.45 million versus the consensus estimate of $189.81 million.
In the second quarter, we achieved record ADCETRIS net sales in the U.S. and Canada,... More
